Please try another search
Bioceltix SA is a Poland-based biopharmaceutical company, which operates in the field of veterinary medicine. The Company deal with the development of candidates for veterinary medicinal products based on the immunomodulatory properties of mesenchymal stem cells used as the active substance of the drug. Entity's products are intended for the treatment of companion animals. The Company carry out research and development works, which enable clinical trials and full registration of medicinal products in the European Medicines Agency, as is the case with medicines and drugs administered to humans.
Name | Age | Since | Title |
---|---|---|---|
Andrzej Jan Grabinski-Baranowski | - | 2022 | Member of Supervisory Board |
Arkadiusz Miazek | - | - | Member of Scientific Board |
Piotr Lembas | 34 | 2022 | Member of Supervisory Board |
Wojciech Aksman | - | - | Member of Supervisory Board |
Maciej Przewozny | - | - | Member of Scientific Board |
Ewa Wieclawik | - | 2022 | Vice Chairman of Supervisory Board |
Maciej Wieloch | - | - | Member of Supervisory Board |
Aleksandra Klimczak | - | - | Member of Scientific Board |
Ewelina Pawlus-Czerniejewska | - | 2022 | Chairman of Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review